more lists either agreeing to allow the food in some capacity (no restriction or partial restriction) or agreeing to fully restrict the food. Disagreement was defi ned as one list fully restricting a food, whereas another list recommended only partial restriction or no restriction.
Combined together, the three lists provided recommendations for 332 unique foods. List A provided guidance on 207 foods, recommending full restriction of 71 (34.3%), partial restriction of 24 (11.6%), and no restriction of 112 (54.1%). List B provided guidance on 203 foods, recommending full restriction of 85 (41.7%), partial restriction of 8 (2.2%), and no restriction on 110 (53.9%). List C provided guidance on 156 foods, recommending full restriction of 62 (39.7%), partial restriction of 20 (12.8%), and no restriction of 74 (47.4%).
With respect to overlap among lists, we found 170 (50.9%) foods were only listed on one of the lists: List A had 67 unique foods; List B had 83 unique foods; and List C had 20 unique foods. With respect to the 162 foods contained on more than one list in which agreement could be assessed, 54 (32.7%) foods had general agreement among all three lists, 73 (45.7%) foods had general agreement on two lists (without a recommendation from a third list), and 35 (21.3%) foods had disagreement among the lists ( Table 1 ) .
In summary, we found that three readily available US-based low FODMAP food lists are oft en discordant with respect to the foods that are listed (lack of overlap in >50%). When the same foods are listed on more than one list, there is generally good agreement, though there are a sizable number of foods (>20%) with recommendations that are in disagreement. It should be To the Editor: A low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet ameliorates gastrointestinal symptoms in adults and children with irritable bowel syndrome ( 1, 2 ) . To follow a low FODMAP diet, dietary education is required as subjects are oft en asked to restrict fermentable substrates for several weeks with gradual reintroduction challenges ( 3, 4 ) . Th e most ideal way to educate subjects regarding the low FODMAP diet is still being actively studied ( 5 ) . Currently the education process oft en includes providing FODMAP food lists that both recommend foods (and amounts), which may be consumed, and those that should be restricted. Th e education process is made more diffi cult by the fact the FODMAP content of foods may diff er according to the country of origin and may require tailoring recommendations to the patient's cultural dietary preferences ( 6 ) . Whether readily available US-based low FODMAP diet food lists provide consistent guidance is unknown.
We evaluated three low FODMAP dietary guidance food lists from sources affi liated with US academic institutions. Th ese lists were readily available (all obtained from the internet in May 2015), contained >150 specifi c food items, and provided specifi c recommendations regarding each listed food. Dietary recommendations for each listed food item was classifi ed into one of three categories: full restriction (food not allowed to be consumed at all); partial restriction (small amount allowed to be consumed), or no restriction. Where two or more lists provided information on the same food, agreement was assessed. General agreement was defi ned as two or case of high-risk individuals. Although oral calcium carbonate is an eff ective antacid, it has been shown to increase gastric acid secretion and serum gastrin levels ( 4 ); hence, presence of calcium carbonate should be duly noted, especially in combination with aspirin.
OTC aspirin-antacid products are sold under various trade names in various countries; they are also available as generic products. Usage of this combination is alarmingly increasing in both the developing and the developed world. We recommend all the physicians and healthcare people to be cautious about the potential complications of OTC antacids in combination with aspirin.
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Th e authors declare no confl ict of interest. diagnosed with infectious gastroenteritis and prescribed an empiric course of antibiotics. Two weeks later, she developed progressively worsening abdominal pain, distention and eventually at week 6 she was hospitalized at our institution. On admission, abdominal X-rays and CT scan of the abdomen revealed global dilation of jejunal and ileal loops up to 7 cm without wall thickening or transition points. No colonic dilation or excessive fecal load was noticed. She underwent a thorough investigation. Stool studies for bacterial and para sitic infections were negative. Th e laboratory data revealed a new onset normocytic anemia (hemoglobin 12.6-9.8 g/dl), C-Reactive Protein (CRP) 16.2 mg/l (normal <5 mg/l), erythrocyte sedimentation rate 18 mm/hr (normal <15 mm/hr) and an antinuclear antibodies (ANA) titer of 1:640. Extractable nuclear antigen antibodies along with IBD and celiac serologies were negative. A fasting breath test did not reveal excessive methane gas. Ante and retrograde double-balloon enteroscopies, which were performed prior to GI motility consultation, failed to identify a transition point or areas of infl ammation. Random biopsies of the stomach, duodenum, jejunum, ileum, and colon were unrevealing. Anti-CdtB testing was noted to be positive ( Figure 1a ), while anti-vinculin was negative ( Figure 1b ) . Patient was started on rifaximin 550 mg TID for 2 weeks with 60% improvement in symptoms. At week 12, there was a positive seroconversion of antivinculin autoantibodies, and anti-CdtB levels remained essentially unchanged. Concomitantly, anemia improved, ANA decreased to 1:160 and CRP normalized. At week 14, both antibodies remained positive and due to persistent bloating and discomfort, she was started on a low FODMAPs diet, polyethylene glycol 3350 and erythromycin 125 mg at bedtime as a pro-motility agent, which led to improvement in her symptoms by 80%. She stopped the bowel regimen shortly thereaft er because of return to baseline. However, at week 20, she again experienced severe abdominal pain/distention, bloating, and constipation. Her anti-CdtB had normalized, while her anti-vinculin was even higher. Her fl are improved with re-initiation of erythromycin. To the Editor: Cytolethal distending toxin (CdtB) is the unifying protein among gram-negative bacilli, and triggers the development of anti-CdtB antibodies in the host ( 1 ) . Molecular mimicry between CdtB and vinculin leads to the formation of autoantibodies to vinculin ( 2 ) . Vinculin is an endogenous protein that plays a key role in neuronal cell adhesion/migration( 3,4 ) and structural integrity ( 5 ) . Th e presence of anti-vinculin antibodies correlates with functional bowel changes and the development of small intestinal bacterial overgrowth ( 2 ) . Patients with diarrheapredominant and mixed-type irritable bowel syndrome (IBS) have signifi cantly elevated levels of anti-CdtB and antivinculin antibodies as compared to patients with celiac disease, infl ammatory bowel disease (IBD) and healthy controls ( 6,7 ). However, the timeline of seroconversion of these antibodies in humans remains unknown. We describe the fi rst case of the longitudinal progression of anti-CdtB and anti-vinculin antibodies in a patient with post-infectious IBS.
A previously healthy 36-year-old female experienced acute watery diarrhea, fever, and emesis aft er a trip to Mexico. She was noted that none of the lists provide guidance on how to combine foods of varying FODMAP content. Further evaluation of low FODMAP food lists (in conjunction with eff orts to build global FODMAP content databases from which these lists may derive) are needed to identify those which are most accurate and eff ective within an educational program.
